Vasa Therapeutics Gains FDA Clearance For VS-041 Clinical Trial
14 Oct 2025 //
INDPHARMAPOST
Vasa Therapeutics Advances Small Molecule VS-041 For HFpEF
13 Oct 2025 //
PR NEWSWIRE
Vasa Completes First-in-Human Study for Heart Failure Drug
04 Jun 2025 //
PR NEWSWIRE
Quotient And Vasa Begin Human Trials Of VS-041 For Novel Heart Failure Therapy
11 Sep 2024 //
PRESS RELEASE
Vasa Therapeutics’ Lead Drug Candidate Enters Clinical Trials
10 Sep 2024 //
CONTRACT PHARMA
Vasa Therapeutics Announces Closing of Seed Financing
03 Jan 2024 //
PR NEWSWIRE

Market Place
Sourcing Support